 Raymond Estacio
Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiovascular Diseases | 19 | 2025 | 2113 | 1.690 |
Why?
| | Community Health Services | 3 | 2017 | 232 | 0.890 |
Why?
| | Diabetes Mellitus, Type 2 | 16 | 2025 | 2521 | 0.850 |
Why?
| | Albuminuria | 7 | 2023 | 185 | 0.850 |
Why?
| | Health Promotion | 4 | 2023 | 744 | 0.710 |
Why?
| | Case Management | 2 | 2012 | 65 | 0.660 |
Why?
| | Hypertension | 9 | 2016 | 1293 | 0.620 |
Why?
| | Community Health Workers | 2 | 2025 | 61 | 0.610 |
Why?
| | Antihypertensive Agents | 7 | 2016 | 493 | 0.560 |
Why?
| | Program Evaluation | 3 | 2017 | 892 | 0.520 |
Why?
| | Renin-Angiotensin System | 2 | 2024 | 84 | 0.510 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 4 | 2024 | 202 | 0.510 |
Why?
| | Lipoproteins, LDL | 2 | 2017 | 119 | 0.500 |
Why?
| | Primary Health Care | 4 | 2017 | 1756 | 0.490 |
Why?
| | Text Messaging | 2 | 2015 | 157 | 0.470 |
Why?
| | Risk Reduction Behavior | 2 | 2017 | 220 | 0.470 |
Why?
| | Glomerular Filtration Rate | 5 | 2024 | 746 | 0.430 |
Why?
| | Diabetes Mellitus | 3 | 2012 | 1035 | 0.430 |
Why?
| | Renal Insufficiency, Chronic | 3 | 2024 | 616 | 0.410 |
Why?
| | Coronary Disease | 2 | 2012 | 385 | 0.380 |
Why?
| | Nursing Care | 1 | 2012 | 41 | 0.370 |
Why?
| | Colorado | 13 | 2025 | 4521 | 0.340 |
Why?
| | Patient Admission | 1 | 2012 | 191 | 0.330 |
Why?
| | Angiotensin Receptor Antagonists | 3 | 2024 | 92 | 0.320 |
Why?
| | Renin | 1 | 2009 | 34 | 0.310 |
Why?
| | Randomized Controlled Trials as Topic | 6 | 2024 | 1465 | 0.300 |
Why?
| | Phosphorus | 1 | 2009 | 97 | 0.300 |
Why?
| | Nursing Diagnosis | 1 | 2008 | 16 | 0.290 |
Why?
| | Patient Acceptance of Health Care | 1 | 2015 | 809 | 0.290 |
Why?
| | Blood Pressure | 7 | 2016 | 1776 | 0.280 |
Why?
| | Cardiac Output, Low | 1 | 2008 | 66 | 0.280 |
Why?
| | Community-Institutional Relations | 1 | 2008 | 99 | 0.280 |
Why?
| | Heart Rate | 2 | 2011 | 831 | 0.280 |
Why?
| | Drug Prescriptions | 1 | 2009 | 251 | 0.270 |
Why?
| | Middle Aged | 30 | 2025 | 33355 | 0.260 |
Why?
| | Tetrazoles | 1 | 2006 | 40 | 0.260 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 38 | 0.260 |
Why?
| | Valine | 1 | 2006 | 82 | 0.260 |
Why?
| | Aged | 21 | 2025 | 23798 | 0.250 |
Why?
| | Risk Factors | 11 | 2023 | 10356 | 0.250 |
Why?
| | Blood Pressure Determination | 2 | 2017 | 156 | 0.240 |
Why?
| | Diabetic Nephropathies | 3 | 2006 | 293 | 0.220 |
Why?
| | Cohort Studies | 10 | 2012 | 5730 | 0.210 |
Why?
| | Lipids | 1 | 2008 | 664 | 0.210 |
Why?
| | Humans | 43 | 2025 | 137514 | 0.200 |
Why?
| | Telemedicine | 1 | 2012 | 852 | 0.200 |
Why?
| | Nisoldipine | 4 | 2009 | 7 | 0.190 |
Why?
| | Enalapril | 4 | 2009 | 16 | 0.190 |
Why?
| | Follow-Up Studies | 9 | 2012 | 5139 | 0.180 |
Why?
| | Diabetic Angiopathies | 5 | 2007 | 258 | 0.180 |
Why?
| | Adult | 17 | 2022 | 37821 | 0.180 |
Why?
| | Medically Underserved Area | 2 | 2015 | 87 | 0.180 |
Why?
| | Renal Insufficiency | 1 | 2023 | 157 | 0.180 |
Why?
| | Proportional Hazards Models | 5 | 2012 | 1263 | 0.170 |
Why?
| | Disease Progression | 3 | 2024 | 2755 | 0.170 |
Why?
| | Male | 28 | 2025 | 67718 | 0.170 |
Why?
| | Life Style | 3 | 2012 | 485 | 0.160 |
Why?
| | Female | 28 | 2025 | 73162 | 0.160 |
Why?
| | Self Care | 2 | 2012 | 374 | 0.150 |
Why?
| | Health Literacy | 1 | 2021 | 169 | 0.150 |
Why?
| | Pilot Projects | 3 | 2025 | 1703 | 0.130 |
Why?
| | Healthy Lifestyle | 1 | 2017 | 34 | 0.130 |
Why?
| | Poverty | 3 | 2017 | 520 | 0.130 |
Why?
| | Prospective Studies | 7 | 2012 | 7598 | 0.130 |
Why?
| | Exercise | 1 | 2008 | 2024 | 0.130 |
Why?
| | Urban Population | 2 | 2017 | 475 | 0.120 |
Why?
| | Diabetic Neuropathies | 3 | 2006 | 94 | 0.120 |
Why?
| | Rural Population | 2 | 2025 | 567 | 0.120 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2008 | 130 | 0.120 |
Why?
| | Triglycerides | 1 | 2017 | 525 | 0.110 |
Why?
| | Educational Status | 1 | 2017 | 483 | 0.110 |
Why?
| | Focus Groups | 2 | 2015 | 512 | 0.110 |
Why?
| | Accelerometry | 1 | 2015 | 97 | 0.110 |
Why?
| | Time Factors | 8 | 2024 | 6817 | 0.110 |
Why?
| | Hyperlipidemias | 2 | 2005 | 120 | 0.110 |
Why?
| | Rural Health Services | 1 | 2015 | 128 | 0.100 |
Why?
| | Risk Assessment | 4 | 2011 | 3439 | 0.100 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 442 | 0.100 |
Why?
| | Diabetic Retinopathy | 2 | 2006 | 189 | 0.100 |
Why?
| | Aged, 80 and over | 4 | 2016 | 7593 | 0.090 |
Why?
| | Geographic Information Systems | 1 | 2011 | 43 | 0.090 |
Why?
| | Bayes Theorem | 2 | 2024 | 407 | 0.090 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2008 | 3708 | 0.090 |
Why?
| | Medically Uninsured | 1 | 2012 | 129 | 0.090 |
Why?
| | Carotid Artery Diseases | 1 | 2011 | 66 | 0.090 |
Why?
| | Guideline Adherence | 2 | 2007 | 549 | 0.090 |
Why?
| | Registries | 2 | 2009 | 2021 | 0.090 |
Why?
| | Patient Compliance | 1 | 2015 | 586 | 0.090 |
Why?
| | Algorithms | 2 | 2008 | 1702 | 0.080 |
Why?
| | Practice Guidelines as Topic | 2 | 2012 | 1580 | 0.080 |
Why?
| | Myocardial Infarction | 3 | 2006 | 1045 | 0.080 |
Why?
| | Motor Activity | 1 | 2015 | 723 | 0.080 |
Why?
| | Fumarates | 1 | 2009 | 9 | 0.080 |
Why?
| | Treatment Outcome | 5 | 2024 | 10821 | 0.080 |
Why?
| | Predictive Value of Tests | 3 | 2010 | 2039 | 0.080 |
Why?
| | Health Maintenance Organizations | 1 | 2009 | 97 | 0.080 |
Why?
| | Urban Health Services | 1 | 2009 | 65 | 0.080 |
Why?
| | Kidney | 2 | 2024 | 1472 | 0.080 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 593 | 0.080 |
Why?
| | Comorbidity | 3 | 2009 | 1618 | 0.080 |
Why?
| | Risk Management | 1 | 2009 | 91 | 0.070 |
Why?
| | Amides | 1 | 2009 | 93 | 0.070 |
Why?
| | Medical Errors | 1 | 2009 | 110 | 0.070 |
Why?
| | Logistic Models | 3 | 2009 | 2064 | 0.070 |
Why?
| | Diabetes Complications | 2 | 2009 | 226 | 0.070 |
Why?
| | Retrospective Studies | 5 | 2024 | 15628 | 0.070 |
Why?
| | Multivariate Analysis | 2 | 2009 | 1524 | 0.070 |
Why?
| | Minority Groups | 1 | 2010 | 269 | 0.070 |
Why?
| | Socioeconomic Factors | 2 | 2009 | 1286 | 0.070 |
Why?
| | Medical Records Systems, Computerized | 1 | 2008 | 93 | 0.070 |
Why?
| | Disease Management | 1 | 2012 | 625 | 0.070 |
Why?
| | Health Services Accessibility | 1 | 2015 | 976 | 0.070 |
Why?
| | Blood Glucose | 1 | 2017 | 2183 | 0.070 |
Why?
| | Electrocardiography | 2 | 2008 | 632 | 0.070 |
Why?
| | Young Adult | 2 | 2015 | 13243 | 0.070 |
Why?
| | Motivation | 1 | 2012 | 571 | 0.070 |
Why?
| | Valsartan | 1 | 2006 | 29 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2012 | 2857 | 0.060 |
Why?
| | Health Status | 1 | 2011 | 784 | 0.060 |
Why?
| | Kidney Function Tests | 1 | 2006 | 158 | 0.060 |
Why?
| | Program Development | 1 | 2008 | 366 | 0.060 |
Why?
| | Stroke | 3 | 2003 | 1129 | 0.060 |
Why?
| | Kidney Diseases | 1 | 2009 | 407 | 0.060 |
Why?
| | Creatinine | 2 | 2023 | 501 | 0.060 |
Why?
| | Quality Assurance, Health Care | 1 | 2007 | 324 | 0.060 |
Why?
| | Survival Analysis | 1 | 2008 | 1320 | 0.060 |
Why?
| | Exercise Tolerance | 1 | 2006 | 278 | 0.060 |
Why?
| | Reagent Strips | 1 | 2004 | 8 | 0.060 |
Why?
| | Mass Screening | 1 | 2012 | 1264 | 0.050 |
Why?
| | Electronic Health Records | 1 | 2012 | 1040 | 0.050 |
Why?
| | Renal Replacement Therapy | 1 | 2024 | 92 | 0.050 |
Why?
| | Calcium | 1 | 2009 | 1233 | 0.050 |
Why?
| | Peripheral Vascular Diseases | 1 | 2003 | 103 | 0.050 |
Why?
| | Incidence | 4 | 2011 | 2792 | 0.050 |
Why?
| | Research Design | 1 | 2008 | 1116 | 0.050 |
Why?
| | Heart Ventricles | 1 | 2006 | 792 | 0.040 |
Why?
| | Patient Education as Topic | 1 | 2005 | 766 | 0.040 |
Why?
| | Renal Dialysis | 1 | 2024 | 434 | 0.040 |
Why?
| | Prognosis | 1 | 2008 | 4031 | 0.040 |
Why?
| | Smoking | 1 | 2006 | 1639 | 0.040 |
Why?
| | Kidney Transplantation | 1 | 2024 | 701 | 0.030 |
Why?
| | Odds Ratio | 3 | 2005 | 1063 | 0.030 |
Why?
| | Chi-Square Distribution | 2 | 2010 | 533 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2025 | 1285 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1619 | 0.030 |
Why?
| | Hospitals | 2 | 2009 | 678 | 0.030 |
Why?
| | Adolescent | 1 | 2012 | 21555 | 0.030 |
Why?
| | United States | 3 | 2021 | 14696 | 0.020 |
Why?
| | Biomarkers | 1 | 2023 | 4172 | 0.020 |
Why?
| | Heart Failure | 1 | 2004 | 2222 | 0.020 |
Why?
| | Reminder Systems | 1 | 2012 | 176 | 0.020 |
Why?
| | Information Dissemination | 1 | 2012 | 218 | 0.020 |
Why?
| | Cross-Sectional Studies | 2 | 2011 | 5427 | 0.020 |
Why?
| | Medication Errors | 1 | 2009 | 96 | 0.020 |
Why?
| | Mexican Americans | 1 | 2010 | 117 | 0.020 |
Why?
| | ROC Curve | 1 | 2010 | 547 | 0.020 |
Why?
| | Health Surveys | 1 | 2010 | 520 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2012 | 657 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 892 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2008 | 316 | 0.020 |
Why?
| | Medical Audit | 1 | 2007 | 76 | 0.020 |
Why?
| | Vascular Diseases | 1 | 2009 | 244 | 0.020 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2012 | 640 | 0.020 |
Why?
| | Public Policy | 1 | 2006 | 82 | 0.020 |
Why?
| | Hospitalization | 2 | 2006 | 2197 | 0.010 |
Why?
| | Smoking Prevention | 1 | 2006 | 188 | 0.010 |
Why?
| | Smoke | 1 | 2006 | 144 | 0.010 |
Why?
| | Specific Gravity | 1 | 2004 | 11 | 0.010 |
Why?
| | Exercise Test | 1 | 2006 | 621 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2006 | 684 | 0.010 |
Why?
| | Chronic Disease | 1 | 2009 | 1790 | 0.010 |
Why?
| | Survival Rate | 1 | 2008 | 1980 | 0.010 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2012 | 1332 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2003 | 328 | 0.010 |
Why?
| | Survivors | 1 | 2006 | 489 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2007 | 746 | 0.010 |
Why?
| | Hypolipidemic Agents | 1 | 2003 | 92 | 0.010 |
Why?
| | Calcium Channel Blockers | 1 | 2003 | 168 | 0.010 |
Why?
| | Age Factors | 1 | 2010 | 3301 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2006 | 447 | 0.010 |
Why?
| | Death, Sudden, Cardiac | 1 | 2003 | 184 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2002 | 288 | 0.010 |
Why?
| | Internet | 1 | 2005 | 656 | 0.010 |
Why?
| | Physician-Patient Relations | 1 | 2005 | 552 | 0.010 |
Why?
| | Cholesterol, LDL | 1 | 2003 | 366 | 0.010 |
Why?
| | Patient Discharge | 1 | 2007 | 895 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2005 | 1047 | 0.010 |
Why?
| | Mental Disorders | 1 | 2008 | 1083 | 0.010 |
Why?
| | Substance-Related Disorders | 1 | 2008 | 1079 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2003 | 1987 | 0.010 |
Why?
| | Body Mass Index | 1 | 2006 | 2369 | 0.010 |
Why?
| | Coronary Artery Disease | 1 | 2003 | 703 | 0.010 |
Why?
|
|
Estacio's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|